Cargando…

Association between the CCR5Δ32 polymorphism and preeclampsia

Detalles Bibliográficos
Autores principales:	Paula Telini, Bianca de, Veit, Tiago Degani, Vianna, Priscila, Bogo Chies, José Artur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204081/ http://dx.doi.org/10.1186/1753-6561-8-S4-P70

Ejemplares similares

CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population
por: Kulmann-Leal, Bruna, et al.
Publicado: (2021)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Considerations About the Role of the CCR5 Gene in Juvenile Idiopathic Arthritis - Look at the Whole or Put All Parts Together?
por: Degani Veit, Tiago, et al.
Publicado: (2011)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)

The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005)

Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer’s disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer’s disease)
por: Khorram Khorshid, Hamid Reza, et al.
Publicado: (2012)

New evidence for balancing selection at the HLA-G locus in South Amerindians
por: Veit, Tiago Degani, et al.
Publicado: (2012)

CCR2-64I and CCR5Δ32 Polymorphisms in Korean Patients with Myasthenia Gravis
por: Kim, Hyun Sook, et al.
Publicado: (2007)

The CCR5Δ32 Polymorphism in Brazilian Patients with Sickle Cell Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2014)

The association between CCR5 Δ32 polymorphism and susceptibility to breast cancer
por: Li, Junlong, et al.
Publicado: (2017)

MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma
por: Dhaouadi, Tarak, et al.
Publicado: (2011)

CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019)

A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer
por: Kulmann-Leal, Bruna, et al.
Publicado: (2020)

The global distribution of CCR5 delta 32 polymorphism: role in HIV-1 protection
por: Gupta, Anuroopa, et al.
Publicado: (2012)

Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran
por: Heydarifard, Zahra, et al.
Publicado: (2017)

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
por: Tene, Oren, et al.
Publicado: (2021)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Genetic Variants in Preeclampsia: Lessons From Studies in Latin-American Populations
por: Michita, Rafael Tomoya, et al.
Publicado: (2018)

Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
por: Li, Ting, et al.
Publicado: (2019)

CCR5-Δ32 gene variant frequency in the Turkish Cypriot population
por: Fahrioglu, Umut, et al.
Publicado: (2020)

CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
por: Parczewski, M, et al.
Publicado: (2010)

Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes?
por: Arababadi, Mohammad K., et al.
Publicado: (2009)

CCR5Δ32 mutations do not determine COVID-19 disease course
por: Bernas, Stefanie N., et al.
Publicado: (2021)

COVID-19 prevalence and mortality is associated with the allele frequency of CCR5-Δ32
por: Saadat, Mostafa
Publicado: (2021)

The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population
por: Maestri, Alvino, et al.
Publicado: (2015)

CCR5‐Δ32 polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients
por: Molad, Jeremy, et al.
Publicado: (2022)

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
por: Jensen, Björn-Erik Ole, et al.
Publicado: (2023)

Effect of CCR5-Δ32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis
por: Liu, SiJie, et al.
Publicado: (2012)

Association of CCR5Δ32 Deletion and Human Cytomegalovirus Infection With Colorectal Cancer in Tunisia
por: Chelbi, Hanen, et al.
Publicado: (2021)

CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients
por: D'Angelo, Rosalia, et al.
Publicado: (2011)

Exploring potential impacts of pregnancy-related maternal immune activation and extracellular vesicles on immune alterations observed in autism spectrum disorder
por: Kaminski, Valéria de Lima, et al.
Publicado: (2023)

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2011)

Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?
por: Starčević Čizmarević, Nada, et al.
Publicado: (2020)

CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus
por: Ndikom, Basil Chukwuebuka, et al.
Publicado: (2022)

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
por: Huyveneers, Laura E. P., et al.
Publicado: (2022)

Detection of CCR5Δ32 Mutant Alleles in Heterogeneous Cell Mixtures Using Droplet Digital PCR
por: Sorokina, Alyona, et al.
Publicado: (2022)

Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity—A Preliminary Report
por: Ganczak, Maria, et al.
Publicado: (2017)

The Paradox of High Availability and Low Recognition of Soluble HLA-G by LILRB1 Receptor in Rheumatoid Arthritis Patients
por: Degani Veit, Tiago, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j0cgvutl2uojhrr2tljupkovm5